COVID-19 Antibodies
Showing 1 - 25 of >10,000
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022
Covid19 Trial in Kingman (VITROS Anti-SARS-CoV-2 IgG test)
Completed
- Covid19
- VITROS Anti-SARS-CoV-2 IgG test
-
Kingman, ArizonaKingman Regional Medical Center
Mar 16, 2022
Covid19, SARS-CoV-2 Trial in Orléans (Sampling by venipuncture (and eventually by nasopharyngeal swab))
Recruiting
- Covid19
- SARS-CoV-2
- Sampling by venipuncture (and eventually by nasopharyngeal swab)
-
Orléans, FranceCentre Hospitalier Régional d'Orléans, France
Mar 16, 2022
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment
Recruiting
- COVID-19 Convalescent Plasma Treatment
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Jun 15, 2023
COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
Completed
- Multiple Sclerosis
- Covid19
-
New York, New YorkNYU Langone Health
Nov 2, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Kidney
Completed
- COVID-19 Pandemic
- Transplantation, Kidney
- No intervention
-
Ostrava, CzechiaUniversity Hospital Ostrava
Dec 6, 2022
Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)
Not yet recruiting
- Long COVID
- +2 more
- AER002
- Placebo
-
San Francisco, CaliforniaUCSF/Zuckerberg San Francisco General Hospital
Jun 2, 2023
COVID-19 Trial in Beijing (SA55 Injection, Placebo for SA55 injection)
Recruiting
- COVID-19
- SA55 Injection
- Placebo for SA55 injection
-
Beijing, ChinaBeijing Ditan Hospital Capital Medical University
Sep 20, 2023
SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease
Completed
- COVID-19 Infection
- SARS-CoV-2 antibodies
-
Vandoeuvre les Nancy, US And Canada Only, FranceCHRU de Nancy, Université de Lorraine
Jul 18, 2022
Antibodies and Immunity After Vaccination of Recovered COVID-19
Active, not recruiting
- Long COVID-19
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Aug 3, 2022
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2
Recruiting
- Covid19
- Serologic immunoassays to SARS-CoV-2 antibodies
-
Detroit, MichiganHenry Ford Health System
Dec 13, 2022
COVID-19 Pandemic, D Vitamin Deficiency, Antibody Hypersensitivity Trial in Trabzon (Vitamin D supplement)
Completed
- COVID-19 Pandemic
- +2 more
- Vitamin D supplement
-
Trabzon, TurkeyAvrasya University
Sep 26, 2022
COVID-19 Trial in Petach Tikva (no intervantion)
Active, not recruiting
- COVID-19
- no intervantion
-
Petach Tikva, IsraelSchneider Children's Medical Center
Sep 29, 2022
Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster
Terminated
- Anti-SARS-CoV-2 Antibody Response
- blood and saliva samples will be taken
-
Graz, AustriaMedizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023
COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)
Not yet recruiting
- COVID-19
- SARS CoV 2 Infection
- Collection of biological samples
-
Orléans, FranceCentre Hospitalier Régional d'Orléans, France
Jul 21, 2022
Monitoring the IgG/IgM Antibodies in COVID-19 Patients
Completed
- COVID-19 Infections
- Serodiagnosis of IgG and IgM
-
Bhakkar, Punjab, Pakistan
- +1 more
Jul 18, 2022
Passive Transmission of COVID-19 Antibody From Mother to Infant
Recruiting
- Passive Transmission of Maternal and Infant Antibodies
- sars-cov-2 vaccine or infection
-
Chongqing, Chongqing, ChinaChildren's hospital of chongqing medical university
May 9, 2023
COVID-19, SARS-CoV2 Infection Trial (Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies)
Not yet recruiting
- COVID-19
- SARS-CoV2 Infection
- Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies
- (no location specified)
Jul 14, 2022
COVID-19, SARS CoV 2 Infection Trial in Minneapolis (LumiraDX, RightSign, Case Control)
Completed
- COVID-19
- SARS CoV 2 Infection
- LumiraDX
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 18, 2022
Seroprevalence of Infection-induced SARS-CoV-2 Antibodies in
Recruiting
- COVID-19
- SARS-CoV-2 IgG Antibody testing
-
Hanoi, VietnamVietnam National Children's Hospital
May 3, 2022
Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)
Active, not recruiting
- Coronavirus Infections
- tixagevimab/cilgavimab 150+150 mg
- +2 more
-
Moscow, Russian FederationMoscow City Clinical Hospital 52
Aug 7, 2023
Clinical Significance of Anti-annexin A2 Antibodies in COVID-19
Recruiting
- COVID-19
-
Amiens, FranceCHU Amiens
Feb 17, 2022
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
Completed
- COVID-19
- SARS-CoV-2 Infection
- Quantitative analysis of SARS-CoV-2 antibodies
- Cellular immunity
-
Prague, CzechiaInstitute of Health Information and Statistics of the Czech Repu
Nov 25, 2022
COVID-19 IgG Antibodies in Maternal and Cord Blood Samples
Withdrawn
- Covid19
- +2 more
- (no location specified)
Apr 19, 2022